Completed

Evaluation of the Relationship Between Cardiopulmonary Exercise Testing (CPET ) Abnormalities and Ca-P Status in CKD Stage3-5

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Urogenital Diseases+24

+ Avitaminosis

+ Bone Diseases

Over 18 Years
+5 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: January 2020
See protocol details

Summary

Principal SponsorShahid Beheshti University of Medical Sciences
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2020

Actual date on which the first participant was enrolled.

Cardiopulmonary exercise testing will carry out in Stage 3-5 chronic kidney disease patients ; estimated glomerular filtration rate <60 ml/min/1.73 m2) and biochemistry will be added (Ca P Via D PTH FGF23).

Official TitleEvaluation of the Relationship Between Cardiopulmonary Exercise Testing (CPET ) Abnormalities and Ca-P Status in CKD Stage3-5
NCT04013139
Principal SponsorShahid Beheshti University of Medical Sciences
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesAvitaminosisBone DiseasesBone Diseases, MetabolicCalcium Metabolism DisordersChronic DiseaseDeficiency DiseasesEndocrine System DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsHyperparathyroidismHyperparathyroidism, SecondaryKidney DiseasesMetabolic DiseasesMusculoskeletal DiseasesNutrition DisordersNutritional and Metabolic DiseasesParathyroid DiseasesPathologic ProcessesChronic Kidney Disease-Mineral and Bone DisorderRicketsPathological Conditions, Signs and SymptomsUrologic DiseasesVitamin D DeficiencyDisease AttributesMalnutritionFemale Urogenital DiseasesMale Urogenital Diseases

Criteria

2 inclusion criteria required to participate
CKD Patients with GFR <60 non-dialysis
age<18
3 exclusion criteria prevent from participating
HTN
not signing consent
active coronary disease

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Nooshin Dalili

Tehran, IranOpen Nooshin Dalili in Google Maps
CompletedOne Study Center